vs

Side-by-side financial comparison of AdvanSix Inc. (ASIX) and STONERIDGE INC (SRI). Click either name above to swap in a different company.

AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $205.2M, roughly 1.8× STONERIDGE INC). On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs -6.0%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $2.6M). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs -7.4%).

AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.

Stoneridge Inc is a global designer and manufacturer of advanced electrical and electronic components, integrated systems, and sensor solutions. It serves automotive, commercial vehicle, off-highway, and aerospace sectors, delivering products that boost vehicle safety, efficiency, connectivity, and environmental performance across key global markets.

ASIX vs SRI — Head-to-Head

Bigger by revenue
ASIX
ASIX
1.8× larger
ASIX
$359.9M
$205.2M
SRI
Growing faster (revenue YoY)
ASIX
ASIX
+15.4% gap
ASIX
9.4%
-6.0%
SRI
More free cash flow
ASIX
ASIX
$33.5M more FCF
ASIX
$36.1M
$2.6M
SRI
Faster 2-yr revenue CAGR
ASIX
ASIX
Annualised
ASIX
3.4%
-7.4%
SRI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASIX
ASIX
SRI
SRI
Revenue
$359.9M
$205.2M
Net Profit
$-2.8M
Gross Margin
7.6%
16.2%
Operating Margin
-0.7%
-14.4%
Net Margin
-0.8%
Revenue YoY
9.4%
-6.0%
Net Profit YoY
-892.9%
EPS (diluted)
$-0.11
$-2.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASIX
ASIX
SRI
SRI
Q4 25
$359.9M
$205.2M
Q3 25
$374.5M
$210.3M
Q2 25
$410.0M
$228.0M
Q1 25
$377.8M
$217.9M
Q4 24
$329.1M
$218.2M
Q3 24
$398.2M
$213.8M
Q2 24
$453.5M
$237.1M
Q1 24
$336.8M
$239.2M
Net Profit
ASIX
ASIX
SRI
SRI
Q4 25
$-2.8M
Q3 25
$-2.6M
$-9.4M
Q2 25
$31.4M
$-9.4M
Q1 25
$23.3M
$-7.2M
Q4 24
$352.0K
Q3 24
$22.3M
$-7.1M
Q2 24
$38.9M
$2.8M
Q1 24
$-17.4M
$-6.1M
Gross Margin
ASIX
ASIX
SRI
SRI
Q4 25
7.6%
16.2%
Q3 25
6.8%
20.3%
Q2 25
14.3%
21.5%
Q1 25
14.2%
21.2%
Q4 24
3.4%
19.5%
Q3 24
14.4%
20.8%
Q2 24
17.9%
22.7%
Q1 24
0.9%
20.2%
Operating Margin
ASIX
ASIX
SRI
SRI
Q4 25
-0.7%
-14.4%
Q3 25
-0.9%
-1.6%
Q2 25
7.7%
-1.1%
Q1 25
7.7%
-1.5%
Q4 24
-3.9%
-2.0%
Q3 24
7.5%
0.1%
Q2 24
11.5%
1.4%
Q1 24
-7.0%
0.1%
Net Margin
ASIX
ASIX
SRI
SRI
Q4 25
-0.8%
Q3 25
-0.7%
-4.5%
Q2 25
7.7%
-4.1%
Q1 25
6.2%
-3.3%
Q4 24
0.1%
Q3 24
5.6%
-3.3%
Q2 24
8.6%
1.2%
Q1 24
-5.2%
-2.6%
EPS (diluted)
ASIX
ASIX
SRI
SRI
Q4 25
$-0.11
$-2.76
Q3 25
$-0.10
$-0.34
Q2 25
$1.15
$-0.34
Q1 25
$0.86
$-0.26
Q4 24
$0.02
$-0.22
Q3 24
$0.82
$-0.26
Q2 24
$1.43
$0.10
Q1 24
$-0.65
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASIX
ASIX
SRI
SRI
Cash + ST InvestmentsLiquidity on hand
$19.8M
$66.3M
Total DebtLower is stronger
$180.9M
Stockholders' EquityBook value
$815.2M
$179.8M
Total Assets
$1.7B
$551.2M
Debt / EquityLower = less leverage
1.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASIX
ASIX
SRI
SRI
Q4 25
$19.8M
$66.3M
Q3 25
$23.7M
$54.0M
Q2 25
$18.4M
$49.8M
Q1 25
$8.3M
$79.1M
Q4 24
$19.6M
$71.8M
Q3 24
$17.3M
$54.1M
Q2 24
$12.1M
$42.1M
Q1 24
$20.6M
$48.4M
Total Debt
ASIX
ASIX
SRI
SRI
Q4 25
$180.9M
Q3 25
Q2 25
Q1 25
Q4 24
$201.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASIX
ASIX
SRI
SRI
Q4 25
$815.2M
$179.8M
Q3 25
$818.2M
$251.2M
Q2 25
$823.7M
$260.5M
Q1 25
$794.4M
$253.1M
Q4 24
$774.6M
$245.3M
Q3 24
$766.4M
$271.4M
Q2 24
$746.6M
$270.5M
Q1 24
$713.2M
$277.3M
Total Assets
ASIX
ASIX
SRI
SRI
Q4 25
$1.7B
$551.2M
Q3 25
$1.7B
$632.1M
Q2 25
$1.6B
$639.4M
Q1 25
$1.6B
$657.4M
Q4 24
$1.6B
$621.6M
Q3 24
$1.5B
$662.5M
Q2 24
$1.5B
$666.7M
Q1 24
$1.5B
$675.4M
Debt / Equity
ASIX
ASIX
SRI
SRI
Q4 25
1.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.82×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASIX
ASIX
SRI
SRI
Operating Cash FlowLast quarter
$63.7M
$8.8M
Free Cash FlowOCF − Capex
$36.1M
$2.6M
FCF MarginFCF / Revenue
10.0%
1.3%
Capex IntensityCapex / Revenue
7.7%
3.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$6.4M
$12.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASIX
ASIX
SRI
SRI
Q4 25
$63.7M
$8.8M
Q3 25
$26.6M
$3.6M
Q2 25
$21.1M
$10.7M
Q1 25
$11.4M
$10.9M
Q4 24
$64.2M
$19.2M
Q3 24
$57.3M
$10.8M
Q2 24
$50.2M
$8.7M
Q1 24
$-36.2M
$9.1M
Free Cash Flow
ASIX
ASIX
SRI
SRI
Q4 25
$36.1M
$2.6M
Q3 25
$66.0K
$-2.7M
Q2 25
$-7.2M
$7.4M
Q1 25
$-22.6M
$4.8M
Q4 24
$29.8M
$14.0M
Q3 24
$26.8M
$4.6M
Q2 24
$16.7M
$1.5M
Q1 24
$-71.6M
$3.3M
FCF Margin
ASIX
ASIX
SRI
SRI
Q4 25
10.0%
1.3%
Q3 25
0.0%
-1.3%
Q2 25
-1.7%
3.3%
Q1 25
-6.0%
2.2%
Q4 24
9.1%
6.4%
Q3 24
6.7%
2.2%
Q2 24
3.7%
0.6%
Q1 24
-21.3%
1.4%
Capex Intensity
ASIX
ASIX
SRI
SRI
Q4 25
7.7%
3.0%
Q3 25
7.1%
3.0%
Q2 25
6.9%
1.4%
Q1 25
9.0%
2.8%
Q4 24
10.4%
2.4%
Q3 24
7.7%
2.9%
Q2 24
7.4%
3.0%
Q1 24
10.5%
2.4%
Cash Conversion
ASIX
ASIX
SRI
SRI
Q4 25
Q3 25
Q2 25
0.67×
Q1 25
0.49×
Q4 24
182.29×
Q3 24
2.57×
Q2 24
1.29×
3.11×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASIX
ASIX

Plant Nutrients$140.0M39%
Chemical Intermediates$92.8M26%
Caprolactam$64.4M18%
Nylon Resins$62.8M17%

SRI
SRI

Control Devices$51.7M25%
Electronics$38.0M19%
EE$34.2M17%
SE$28.6M14%
NL$24.5M12%
Stoneridge Brazil$14.1M7%
Asia Pacific$13.1M6%

Related Comparisons